EORTC Quality of Life Measurement in Males With Breast Cancer

NCT07455110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2026-03-27

No results posted yet for this study

Summary

Around 1% of all new cases of breast cancer (BC) diagnosed annually occur in men. Most research to date has focused on female breast cancer (FBC). So what is known about breast cancer in men has been mostly derived from the research and treatment of FBC. Comprehensive, prospective data about Quality of life in men treated for BC is lacking. Therefore, a validated worldwide questionnaire for male BC will be developed.

Conditions

Interventions

BEHAVIORAL

structured Interview

Interviews with patients and health care professionals(HCP)

Sponsors & Collaborators

  • Mugla Sitki Kocman University School of Medicine

    collaborator UNKNOWN
  • UNED Pamplona

    collaborator UNKNOWN
  • Unidad de cancer

    collaborator UNKNOWN
  • Sørlandet Hospital, Kristiansand (SSHF)

    collaborator UNKNOWN
  • Medizinische Universität Innsbruck

    collaborator UNKNOWN
  • Sunnybrook Health Science Centre

    collaborator UNKNOWN
  • East Kent Gynaecological Oncology Centre, Queen Elizabeth the Queen Mother Hospital

    collaborator UNKNOWN
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Aarhus University and University of Southern Denmark

    collaborator UNKNOWN
  • University of Roma La Sapienza

    collaborator OTHER
  • Helios University Hospital Wuppertal

    lead OTHER

Principal Investigators

  • Vesna Bjelic-Radisic, Prof · Helios University Clinic Wuppertal, University Witten/Herdecke

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2023-03-20
Completion
2023-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07455110 on ClinicalTrials.gov